Search results
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 4 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 6 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...
CVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoCVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript May 1, 2024 CVS Health...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 2 days agoSales of Tyvaso DPI were driven by higher volumes and increased commercialization utilization of the...
Q1 2024 Alignment Healthcare Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoIn conclusion, I'd like to thank each of our employees for being part of the team that is raising the standard for what it means to do Medicare ...
Earnings call: GSK forecasts growth with strong Q1 performance
Investing.com· 15 hours agoGSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...
Analysts revise CVS stock targets after Aetna Medicare Advantage earnings plunge
TheStreet.com· 2 days agoHealth shares. "We have a track record of successfully navigating complex industry pressure, and we’ll continue to demonstrate our resilience," the president and CEO of CVS Health told analysts ...
Osteoporosis screening rates low for Asian American Medicare beneficiaries
Medical Xpress· 3 days agoRates of dual-energy X-ray absorptiometry (DXA) screening for osteoporosis are lower than expected...
Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch
Quartz· 3 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...